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Abstract
The Brugada syndrome is characterized by ST segment elevation in the right precodial leads V1-V3
on surface ECG accompanied by episodes of ventricular fibrillation causing syncope or even sudden
death. The molecular and cellular mechanisms that lead to Brugada syndrome are not yet
completely understood. However, SCN5A is the most well known responsible gene that causes
Brugada syndrome. Until now, more than a hundred mutations in SCN5A responsible for Brugada
syndrome have been described. Functional studies of some of the mutations have been performed
and show that a reduction of human cardiac sodium current accounts for the pathogenesis of
Brugada syndrome. Here we reported three novel SCN5A mutations identified in patients with
Brugada syndrome in Taiwan (p.I848fs, p.R965C, and p.1876insM). Their electrophysiological
properties were altered by patch clamp analysis. The p.I848fs mutant generated no sodium current.
The p.R965C and p.1876insM mutants produced channels with steady state inactivation shifted to
a more negative potential (9.4 mV and 8.5 mV respectively), and slower recovery from inactivation.
Besides, the steady state activation of p.1876insM was altered and was shifted to a more positive
potential (7.69 mV). In conclusion, the SCN5A channel defect related to Brugada syndrome might
be diverse but all resulted in a decrease of sodium current.
Background
SCN5A encodes the alpha subunit of human cardiac
sodium channel, which is responsible for the generation
of cardiac action potential and for rapid impulse conduc-
tion through the myocardium[1]. Mutations in SCN5A
cause inherited arrthymia syndrome such as Long QT syn-
drome (LQT3), Brugada syndrome, isolated conduction
disease, atrial stanstill, congenital sick sinus syndrome or
sudden infant death syndrome [2,3]. Chen et al. first
reported in 1998 that loss of function mutations of
SCN5A accounts for the most well-known genetic basis
for Brugada syndrom[4]. However, for the clinically diag-
nosed cases, only no more than 20% carry SCN5A muta-
tions[5]. Mutations in other genes that cause Brugada
syndrome have been reported. These genes include glyc-
erol-3-phosphate dehydrogenase 1-like gene (GPD1L),
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the alpha subunit of the L-type calcium channel
(CACNA1C), the beta subunit of the L-type calcium chan-
nel (CACNB2b), and the sodium channel beta subunit
(SCN1B) [6-8]. However, SCN5A is so far still the most
often reported gene causing Brugada syndrome. Altered
electrophysiology, trafficking, expression level, or interac-
tion with its intracellular components all has been
reported to account for the mechanisms contribute to loss
of function of SCN5A [9-12]. In this study, we investi-
gated on three SCN5A mutation identified in patients
with Brugada syndrome in Taiwan and tried to identify
the underlying mechanism of three mutations that con-
tribute to Brugada syndrome.
Materials and methods
Cloning of SCN5A and SCN1B
Total RNA was extracted from human heart tissue using
trizol (Invitrogen, USA) according to manufacturer's pro-
tocol. Complimentary DNA was synthesized using 200
units of Superscript III reverse transcriptase (Invitrogen,
USA) at 52°C for 50 min in the presence of 5 g of total
RNA, 0.5 g of oligo-dT primers, 0.004 mM DTT, 5%
DMSO and 0.2 mM dNTPs, and the reaction product was
used as the template in subsequent polymerase chain
reaction(PCR). The PCR product for SCN1B was first
cloned into pAAV-IRES-hrGFP (Stratagene, USA) with
BamH I/Xho I and subcloned into the Bgl II recognition
sequence of pBudCE4.1 (Invitrogen) with BamH I/Bgl II.
The subclone procedure allowed dicistronic expression of
SCN1B and humanized Renilla reniformis green fluores-
cent protein (hrGFP) under the control of EF-1 pro-
moter. The PCR product of SCN5A was cloned into the
pBudCE4.1 containing SCN1B with Hind III/Xba I under
the control of CMV promoter. Besides, a myc epitope
EQKLISEEDL was introduced in frame at the N terminus
of SCN5A. The base sequence of the SCN5A and SCN1B
clone were analyzed and were identical to the published
SCN5A (hH1, NM_198056) and SCN1B (NM_199037)
sequence.
Site directed mutagenesis
The p.I848fs, p.R965C, and p.1876insM mutants were
generated using the QuickChange Site-Directed Mutagen-
esis system (Stratagene). All constructs were sequenced to
verify the mutation and to rule out possible PCR errors.
Culture and transfection of HEK293T cells
HEK293T cells were grown in Dulbecco's modified Eagle's
medium supplemented with 10% fetal bovine serum and
antibiotics at 37°C and 5% CO2. Jetpei (Polyplus) was
used as the reagent for transient transfection. Briefly, 3 ×
105 HEK293T cells were seeded into a 35 mm dish the day
before transfection. Onto the cell monolayer were added
3 g plasmid and 6 l Jetpei in 200 gl sodium chloride
solution (150 mM). The cells were harvested by PBS con-
taining 1% EDTA for patch clamp or for western blot 48–
56 hrs after transfection.
Patch clamp and data analysis
Cells were incubated in bath solution containing (mM):
NaCl 145, KCl 4, CaCl 1.8, MgCl 1, HEPES-NaOH pH
7.35. Expressed currents were recorded by whole-cell
patch-clamp technique using a patch-clamp amplifier
(Dagan 8900). The pipette solution contained (mM) NaF
10, CsF 110, CsCl 20, EGTA 10 and HEPES 10 (pH 7.35
with CsOH). Pipettes were made from borosilicate glass
capillaries and had tip resistances between 1.5 and 2.5
MÙ when filled with the pipette solution. All of the elec-
trical recordings were performed at room temperature
(24–26°C). Data acquisition was performed through a
DigiData 1200 amplifier controlled by pClamp 6.0, and
the results were analyzed using Clampfit 9.0.
To measure the cell capacitance, a step voltage (from -80
mV to -70 mV) was applied to the cell and accessed the
area under the capacity transient. The cell capacitance was
obtained by dividing the area under the capacity transient
with the factor 10. The plots of voltage dependent steady
state activation and inactivation were fitted by Boltzmann
equation: Y = 1/[1+exp(V -Vm)/k], where Vm is the volt-
age at which sodium current is half-maximally activated,
and k was the slope factor. Time constants of inactivation
were obtained by fitting the decaying phase of current
trace with one exponential equation: Y = A*exp(-t/) + C.
To analyze the kinetics of recovery from inactivation, two-
exponential equation was as in the format: Y = A*[1-exp(-
t/f)]+(1-A)*[1-exp(-t/s)].
Immunocytochemistry and Confocal imaging
HEK293T cells were cultivated on chamber slips (UNUC)
and transiently transfected with WT, p.I848fs, p.R965C, or
p.1876insM. Forty-eight hours after transfection, the cul-
ture medium were removed and cells were washed with
ice-cold PBS. The cells were then fixed by incubation in
4% paraformaldehyde at room temperature for 30 min
and permeabilized with PBS containing 0.5% tween 20
and 10% BSA for another 30 min. Before comfocal imag-
ing, cells were incubated in PBS containing primary anti-
body (anti-myc 1:500, Upstate) overnight at 4°C and
secondary antibody anti-mouse IgG coujugated with Cy3
(1:2000, Sigma) for 30 min. Confocal images were
obtained and analyzed using a Leica TCS SP5 Spectral
Confocal System.
Surface biotinylation reaction
Sulfo-NHS-LC-Biotin (PIERCE) was used as the reagent
for labeling of cell surface proteins. Briefly, the transfected
cells were washed and harvested using 1%EDTA (pre-
pared in PBS). The cell pellets were resuspended in PBS
containing Sulfo-NHS-LC-Biotin (2 mg/ml) and rotatedJournal of Biomedical Science 2009, 16:23 http://www.jbiomedsci.com/content/16/1/23
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at 4°C for 30 min. The biotinylation reaction was blocked
by adding equal volume of 0.1 M glycine (in PBS) and
rotated for mixing for 20 min at 4°C. The cells were then
centrifuged and wash 3 times with PBS and subjected to
protein extraction and Western blotting.
Western blotting
The cells for protein extraction were collected 48 to 56
hours after transfection by centrifuging at 500 g for 5 min.
The pellet was then incubated in lysis buffer (1% Triton-X
100 pH 8.0, 50 mM Tris-HCl, 300 mM NaCl, 5 mM EDTA,
0.02% sodium azide, 1 mM PMSF, 2 g/ml leupeptin, and
5 g/ml apotinin) for 30 min, and centrifuged at 15000 g
for 15 min.
For analysis of biotinylated protein, the extracted proteins
were mixed with anti-myc antibody (Upstate) and protein
A/G plus (Santa Cruz) for 4 hrs, washed 4 times with lysis
buffer and the immunoprecipitated proteins were
released from the beads by heating at 95°C for 5 min in
5× sample buffer. The collected proteins were subjected to
SDS-PAGE, transferred to PVDF membrane, and detected
by Western blotting analysis using HRP conjugated
streptavidin (PIERCE).
Data management and statistical analysis
Data of patch clamp were ananlyzed using clampfit 9.0,
and photoshop 8.0 was used for confocal image process-
ing. Prism 4.0 was used for figure plotting, curve fitting
and statistical calculation. Data were presented as mean ±
standard error of the mean (SEM). Statistical comparisons
were compared to WT using unpaired Student's t test for
current density, Vm, slop factor, and time constants. Mul-
tiple group comparison was made using one way ANOVA
followed by Tukey test. P values less than 0.05 were taken
as statistically significant.
Results
Genetic analysis and the electrocardiographic (ECG) 
characteristics
We had identified three SCN5A mutations in three
patients with Brugada syndromes in Taiwan. Among
them, two were novel (c.2540 del C, and c.5626 ins ATG)
and one had been reported (c.2893 C>T)[13]. c.2540 del
C introduced a new stop codon and thus produced a trun-
cated protein with 880 amino acid residues
(p.I848SfsX33). c.2893 C>T was a mutation in substitu-
tion form and changed the amino acid at position 965 of
SCN5A form arginine to cysteine (p.R965C). The last
mutation, c.5626 ins ATG had a 3 bp insertion and
allowed an in frame insertion of methionine at amino
acid 1876 (p.1876 insM). The surface 12-lead ECG of the
three patients with Brugada syndrome carrying SCN5A
mutation all revealed ST segment elevation characteristic
of Brugada syndrome (Figure 1). The PR intervals for
p.I848fs, p.R965C and p.1876insM carriers were 177,
180, and 174 ms respectively. They all had a similar clini-
cal presentation of aborted sudden cardiac death due to
ventricular fibrillation.
Sodium current elicited by WT and mutant cardiac sodium 
channels
Figure 2A displayed the representative current traces of
WT and three mutants. Their current-voltage relationships
were shown in Figure 2B. WT, p.R965C, and p.1876 insM
produced comparable sodium currents while p.I848fs
elicited currents that were hardly detectable. The current
densities among WT, p.R965C, or p.1876insM, were not
statistically significant (Figure 2C).
Voltage dependent steady state activation and steady 
state inactivation
Since p.I848fs channels produced hardly detectable
sodium current, we performed kinetics analysis for WT,
p.R965C, and p.1876insM channels only. As shown in
Figure 3A, the activation curves of WT and p.R965C were
nearly superimposed. However, p.1876insM showed a
right-shift of the steady state activation curve, indicating it
required more a positive potential to open. When fitted
with Boltzman equation, the obtained Vm were -42.56 ±
0.81 for WT, -41.11 ± 0.82 for p.R965C, and -34.87 ± 1.80
for p.1876insM (p < 0.01). Slope factors were 5.61 ± 0.71
for WT, 4.71 ± 0.77 for p.R965C and 8.09 ± 1.65 for
p.1876insM (p < 0.05). Besides, both p.R965C and
p.1876insM showed a left shift in the steady state inacti-
vation curve when compared to WT, which suggested a
reduced availability of open channel under physiological
condition. The obtained inactivation Vm were -84.30 ±
1.20 for WT, -93.70 ± 0.84 for p.R965C (p < 0.01), and -
92.80 ± 0.90 for p.1876insM (p < 0.05). Slope factors
were 7.89 ± 1.06 for WT, 6.67 ± 0.73 for p.R965C and 8.33
± 0.81 for p.1876insM.
Time constants of fast inactivation
On stimulation, sodium channel open and inactivated
rapidly. Fast inactivation was accessed by analysis of time
constant of fast inactivation. By fitting the decaying phase
of sodium current, we found that the time constants of
inactivation for p.1876insM were significant larger than
WT (Figure 3B). This suggested that p.1876insM inacti-
vated slower than WT during depolarizing stimulation.
Recovery from inactivation and development of slow 
inactivation
Sodium channel inactivates rapidly by depolarizing stim-
uli but also recovers from inactivation rapidly during
hyperpolarizing potential between depolarizing stimuli.
Recovery from inactivation was evaluated by applying a
long depolarizing pulse (20 mV, 500 ms) followed by a
hyperpolarizing pulse (-120 mV) with time intervals toJournal of Biomedical Science 2009, 16:23 http://www.jbiomedsci.com/content/16/1/23
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allow the channels to recover from inactivation. During
the hyperpolarizing pulse, a brief depolarizing pulse was
applied and the current elicited at this stage was analyzed.
When the data were fitted with two exponential equation,
the obtained parameters were as followed. For WT, A =
0.83 ± 0.03, f = 6.19 ± 0.33, and s = 59.85 ± 11.17. For
p.R965C, A = 0.82 ± 0.15, f = 8.06 ± 0.61 (p < 0.01), and
s = 66.12 ± 21.16. For p.1876insM, A = 0.65 ± 0.12, f =
10.7 ± 1.96 (p < 0.01), and s = 58.76 ± 19.85. This sug-
gested that both mutants showed a significantly slower
recovery from inactivation (Figure. 4A). Besides the fast
inactivation, cardiac sodium channel might enter a more
stable state of inactivation called slow inactivation upon
prolonged depolarizing stimuli. Here we apply a depolar-
izing pulse (20 mV) with time intervals as in Figure 3B to
access this property. We found that p.R965C channel was
more prone to develop slow inactivation and this was sta-
tistically significant (Figure 4B).
Surface 12-lead ECG of the three patients with Brugada syndrome carrying SCN5A mutation Figure 1
Surface 12-lead ECG of the three patients with Brugada syndrome carrying SCN5A mutation.Journal of Biomedical Science 2009, 16:23 http://www.jbiomedsci.com/content/16/1/23
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Sodium current recorded on HEK293T cells transfected with SCN5A WT, or mutant plasmids Figure 2
Sodium current recorded on HEK293T cells transfected with SCN5A WT, or mutant plasmids. (A) Representa-
tive current traces. Protocol used was shown in inset. (B) Current-voltage (I-V) relationship of WT, p.I848fs, p.R965C, and 
p.1876insM SCN5A channels (n = 9, 7, 7 and 11 respectively). GFP was used as a negative control and was also shown (n = 4). 
(C) Histogram of current density recorded at -20 mV. The current densities between WT and p.R965C or WT and 
p.1876insM were not statistically significance.Journal of Biomedical Science 2009, 16:23 http://www.jbiomedsci.com/content/16/1/23
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Kinetics of sodium channel activation and inactivation Figure 3
Kinetics of sodium channel activation and inactivation. (A) Voltage dependant steady state activation (n = 10,11, and 8 
for WT, p.R965C, and p.1876insM respectively) and steady state inactivation (n = 10,11, and 8 for WT, p.R965C, and 
p.1876insM respectively). *, p < 0.05; **, p < 0.01 when compared to WT using one way ANOVA followed by Tukey test (B) 
Time constant of inactivation. This was accessed by fitting the decaying phase of current trace obtained as in Figure 2A with 
one exponential equation: Y = Aexp(-t/) + C. *, p < 0.05 when compared to WT
Recovery from inactivation and develop of slow inactivation Figure 4
Recovery from inactivation and develop of slow inactivation. (A) Recovery from inactivation (n = 10,11, and 8 for WT, 
p.R965C, and p.1876insM respectively). The currents recorded at P2 were normalized to that at P1 and were plotted against 
time. Two-exponential equation was used to fit the plot. (B) Develop of slow inactivation. Currents at P2 and P1 were normal-
ized and plotted against time (n = 8, 10, and 6 for WT, p.R965C, and p.1876insM respectively). **, p < 0.01 when compared to 
WT using one way ANOVA followed by Tukey testJournal of Biomedical Science 2009, 16:23 http://www.jbiomedsci.com/content/16/1/23
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Cell surface protein biotinylation and Western blotting
SCN5A encodes the alpha subunit of cardiac sodium
channel and therefore its functional destination in cells
should be the cell surface membrane. We performed cell
surface protein biotinylation reaction to access whether
SCN5A protein reached cell surface membrane. In this
reaction, only cell surface proteins were exposed to bioti-
nylaing reagent and added biotins on them. After immu-
noprecipitated with anti-myc antibody, the
immunoprecipatated complexes were subject to western
blotting and analyzed by HRP conjugated streptavidin,
which recognized biotinylated proteins. Clear presence of
biotinylated proteins for all constructs (WT, p.I848fs,
p.R965C, and p.1876insM) was observed (Figure 5). This
suggested that they were all capable to reach to cell sur-
face.
Intracellular trafficking analysis by confocal imaging
The construct used in this study had a myc epitope fused
to the N-terminus of SCN5A protein so that we might
regard antibody that recognized myc as the one that target
SCN5A. The construct also generated GFP protein dicis-
tronically and we might therefore regard the presence of
GFP protein as the presence of transfected cells. Similar
intracellular distribution for WT and mutants SCN5A pro-
teins, and the presence of red florescence at the periphery
of cells were observed. This suggested that p.I848fs as well
as others were trafficking competent (Figure 6). There
were some strong 'red spot', and this might due to the
immature proteins in ER pool.
Discussion
We characterized three mutations in SCN5A among Tai-
wanese patients with Brugada syndrome using patch
clamp technique, western blotting and confocal imaging.
Western blotting and confocal imaging showed that three
mutants were trafficking-competent. However, their elec-
trophysiological properties were impaired when com-
pared with WT. p.I848fs elicited no sodium current.
p.R965C produced sodium channel with impaired steady
state inactivation, recovery from inactivation and slow
inactivation while p.1876insM generated sodium channel
with altered kinetics of activation, inactivation, and recov-
ery from inactivation. We recognized that a decreased of
sodium current might contribute to Brugada syndrome
because all the three mutations resulted in a decrease of
sodium current. However, the degree of sodium channel
decrease does not seem to correlate with conduction time
such as PR interval. Some other factors might compensate
or play unknown roles in the clinical presentation.
SCN5A encodes the alpha subunit of cardiac sodium
channel, which consists four homologous domains, and
each domain contains six alpha-helical transmembrane
repeats[3]. The frame shift of the p.I848fs mutant located
at the fifth transmembrane segment of domain 2 (DII/S5)
of cardiac sodium channel. Because it produces a protein
with a truncation of more than a half of the WT cardiac
sodium channel protein, the observation that it elicited
no current was reasonable. In constancy with our found-
ing, Shin et al. reported a mutation, W1119X, which
lacked even less amino acids than p.I848fs, failed to gen-
erate any current[14]. Moreover, by western blotting and
confocal imaging analysis, the presence of p.I848fs at
cytoplasmic membrane suggested that the remained
amino acid residues in I848fs were sufficient for the
processing and trafficking of cardiac sodium channel.
The substituted amino acid p.R965C located at the intrac-
ellular loop between domain II and domain III of SCN5A
protein (DII-DIII). Mutations located at this region had
been reported http://www.fsm.it/cardmoc/, but few had
Representative western blotting of WT, p.I848fs. p.R965C,  and p.1876insM SCN5A channels from 4 independent exper- iments Figure 5
Representative western blotting of WT, p.I848fs. 
p.R965C, and p.1876insM SCN5A channels from 4 
independent experiments. HEK293T transfected with 
WT or mutant plasmid were firstly treated with cell imper-
meable biotinylation reagent and total proteins were 
extracted from these cells. After immunoprecipitated with 
anti-myc antibody, which recognized the epitope added on all 
SCN5A constructs, the immunoprecipitated complex were 
subject to western blotting and reacted with HRP conjugated 
streptavidin. All four SCN5A constructs displayed bands by 
western blotting, indicating they were all subject to biotinyla-
tion reaction. This suggested that they all reached cytoplas-
mic membrane. Note that p.I848fs produced a truncated 
protein with a smaller molecular weigh than others.Journal of Biomedical Science 2009, 16:23 http://www.jbiomedsci.com/content/16/1/23
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Immunocytochemistry staining revealed by confocal image (total cells analyzed were 25, 18, 6, and 9 for WT, p.I848fs,  p.R965C, and p.1876insM respectively from 7 independent experiments) Figure 6
Immunocytochemistry staining revealed by confocal image (total cells analyzed were 25, 18, 6, and 9 for WT, 
p.I848fs, p.R965C, and p.1876insM respectively from 7 independent experiments). The presence of red fluores-
cence (anti-myc antibody) at cytoplasmic membrane indicated that WT as well as other mutants were all trafficking competent. 
The red spot at the center of cell might be immature SCN5A protein in ER.Journal of Biomedical Science 2009, 16:23 http://www.jbiomedsci.com/content/16/1/23
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been characterized by functional studies. Arginine at posi-
tion 965, together with nearby amino acids, formed a spe-
cialized structure with putative amphiphilic helix carrying
regularly arranged positive charges which resembling an
S4 segment of voltage-gated ion channels[15]. The
sequence here was unique to cardiac sodium channel.
Camacho et al. had reported a splice variant lacking this
sequence and showed that was associated with altered
steady state activation, and inactivation[15]. Besides,
Camacho et al. also pointed out that three positively
charged arginine in this region were involved in current
density. Arginine at 965 position located at one of them
(the other two were at 968 and 971). The substitution of
p.R965C from the positively charged aginine to a neutral
cysteine might influence channel gating properties. In this
study we observed a left shift in inactivation curve, and
altered recovery from inactivation. The current density
was not significantly changed, although it seemed to be
smaller. Besides, the altered steady state inactivation
might partly be due to impaired slow inactivation as we
observed.
There had been many functional studies reported for the
mutations in the carboxyl-terminal of cardiac sodium
channel and implied its role in controlling channel inac-
tivation [16-18]. As predicted by the amino acid segment,
the carboxyl-terminal domain of cardiac sodium channel
can to be divided into two parts. The proximal part was
structured and forms six helices, whereas the distal part
(about 100 amino acids) is unstructured. Loss of the pre-
dicted six helices greatly destabilizes inactivation while
truncation of the unstructured part does not affect no
channel gating[19]. The six helices of the carboxyl -termi-
nal might interact with the linker of domain III and
domain IV during inactivation. Changes of amino acid at
these regions influences inactivation and contributes to
Brugada syndrome, LQT3 or both, such as del KPQ1507-
1509 (DIII-DIV), E1784K (C-terminal) or 1795insD(C-
terminal) [20-23]]. The insertion of the p.1876insM
mutant located at the fifth helices of the carboxyl-terminal
and this mutation was found to have an altered inactiva-
tion. This was in agreement with the previous reports [16-
18]. Besides inactivation, mutations located at the car-
boxyl-terminal might affect other gating parameters [20-
22,24-26]. Rivolta et al. reported two mutations, Y1795H
and Y1795C, contributing to Brugada syndrome and
LQT3 respectively [24]. These two mutations affected
steady state inactivation, fast inactivation, current density,
and were more prone to enter slow inactivation without
affecting steady state activation and recovery from inacti-
vation. Similar findings were also observed in the Brugada
syndrome mutation, C1859S as reported by Petitprez et
al[25]. In this study, we found that the p.1876insM
mutant at the carboxyl-terminal affected more than these
parameters. Change of steady state activation of
p.1876insM was observed as Shirai et al. observed in
T1620M and S1710L [26]. This again proved the impor-
tance of carboxyl-terminal in regulation of cardiac sodium
channel.
Some residues of cardiac sodium channel were important
in regulation of the gating property of channel. Changes
or lacks of these residues might therefore contribute to the
alteration of electrophysiological property as we showed
in this study. The three mutations accounted for Brugada
syndrome all had electrophysiological alteration and con-
tributed to loss of function of cardiac sodium channel. A
more detailed screening of relationship between structure
and channel gating might be worthwhile since similar
results were observed for mutations located at different
positions.
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